Back to top
more

Danaher (DHR)

(Delayed Data from NYSE)

$243.25 USD

243.25
3,475,277

-2.14 (-0.87%)

Updated Nov 11, 2024 04:00 PM ET

After-Market: $243.25 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (89 out of 249)

Industry: Diversified Operations

Zacks News

ITT vs. DHR: Which Stock Should Value Investors Buy Now?

ITT vs. DHR: Which Stock Is the Better Value Option?

CKHUY or DHR: Which Is the Better Value Stock Right Now?

CKHUY vs. DHR: Which Stock Is the Better Value Option?

Danaher (DHR) Up 3.4% Since Last Earnings Report: Can It Continue?

Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CKHUY vs. DHR: Which Stock Is the Better Value Option?

CKHUY vs. DHR: Which Stock Is the Better Value Option?

General Electric (GE) Q1 Earnings Beat Estimates, Down Y/Y

General Electric's (GE) first-quarter 2019 results decline year over year due to weak sales performance and fall in margins. However, results surpass estimates.

The Zacks Analyst Blog Highlights: Roche, Danaher, BlackRock, Kinder Morgan and Allstate

The Zacks Analyst Blog Highlights: Roche, Danaher, BlackRock, Kinder Morgan and Allstate

Mark Vickery headshot

Top Research Reports for Roche, Danaher & BlackRock

Today's Research Daily features new research reports on 16 major stocks, including Roche (RHHBY), Danaher (DHR) and BlackRock (BLK).

Honeywell (HON) Q1 Earnings & Revenues Outpace Estimates

Solid long-cycle businesses in U.S. defense, commercial aerospace, and warehouse and process automation drive Honeywell's (HON) Q1.

Danaher (DHR) Q1 Earnings Top, View Down on Buyout Impact

Danaher's (DHR) first-quarter 2019 results gain from sales growth and DBS initiatives. It lowers projection for 2019 to include the dilutive impact of the BioPharma buyout.

Danaher (DHR) to Report Q1 Earnings: What's in the Offing?

Danaher's (DHR) first-quarter 2019 results to gain from solid product portfolio, innovative capabilities, Danaher Business System and acquired assets. Forex woes, tariffs and high costs drag.

Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mark Vickery headshot

Top Analyst Reports for Mastercard, Honeywell & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Honeywell (HON) and Thermo Fisher (TMO).

UTX or DHR: Which Is the Better Value Stock Right Now?

UTX vs. DHR: Which Stock Is the Better Value Option?

UTX vs. DHR: Which Stock Should Value Investors Buy Now?

UTX vs. DHR: Which Stock Is the Better Value Option?

Danaher to Gain From Solid Demand in Key Markets Amid Risks

Effective implementation of Danaher Business System and solid demand for innovative products are likely to boost Danaher's (DHR) revenues.

Danaher's Stock Offering Proceeds to Fund BioPharma Buyout

Danaher (DHR) successfully completes the offering of common and preferred shares. It intends on using the funds raised to pay for the pending acquisition of General Electric's BioPharma business.

GE Intends to Lower Debt Burden, Boost Dividend Payments

General Electric (GE) seeks to become more competent on the back of its initiatives to improve financial position and strengthen core businesses.

Danaher to Buy BioPharma, Offers Common & Preferred Shares

Danaher (DHR) to gain from the buyout of the BioPharma business. This is likely to strengthen its biologics workflow solutions business. The company offers common and preferred shares.

General Electric (GE) to Divest BioPharma, Closes Wabtec Deal

General Electric (GE) to gain from divestiture of the BioPharma business by using the proceeds to lower debt burden and focus on more important portfolios. It completes GE Transportation divestment.

Company News For Feb 26, 2019

Companies In The News Are: DHR,GE,ONCE,CMTA,CRI

Danaher (DHR) Catches Eye: Stock Jumps 8.5%

Danaher (DHR) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Mark Vickery headshot

Pre-Markets Up, GE Sells Off Biopharma Biz

With President Trump again delaying the 25% tariff rate and GE raising over $21 billion to pay down debt, futures are in the green this morning.

Positive Development on Trade War Front

Positive Development on Trade War Front

Mark Vickery headshot

Pre-Markets Up, GE Sells Off Biopharma Biz

With President Trump again delaying the 25% tariff rate and GE raising over $21 billion to pay down debt, futures are in the green this morning.

The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia

The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia